D J Covell1, J L Robinson1, R S Akhtar1,2, M Grossman2, D Weintraub3, H M Bucklin1, R M Pitkin1, D Riddle1, A Yousef1, J Q Trojanowski1, V M-Y Lee1. 1. Center for Neurodegenerative Disease Research and Institute on Aging, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 2. Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 3. Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Abstract
AIMS: The aim of this study was to test the hypothesis that different conformations of misfolded α-synuclein (α-syn) are present in Parkinson's disease (PD) brain. METHODS: Using two previously characterized conformations of α-syn fibrils, we generated new conformation-selective α-syn monoclonal antibodies (mAbs). We then interrogated multiple brain regions in a well-characterized autopsy cohort of PD patients (n = 49) with these mAbs, Syn7015 and Syn9029. RESULTS: Syn7015 detects Lewy bodies (LBs) and Lewy neurites (LNs) formed by pathological α-syn in all brain regions tested, and is particularly sensitive to LNs and small Lewy dots, inclusions believed to form early in the disease. Further, we observed colocalization between Syn7015 and an early marker of α-syn pathology formation, phospho-Ser129-α-syn, and a lack of extensive colocalization with markers of more mature pathology. In comparison, Syn9029 detects Lewy pathology in all regions examined, but indicates significantly fewer LNs than Syn7015. In addition, colocalization of Syn9029 with later markers of α-syn pathology maturation (ubiquitin and P62) suggests that the pathology detected by Syn9029 is older. Semiquantitative scoring of both LN and LB pathology in nine brain regions further established this trend, with Syn7015 LN scores consistently higher than Syn9029 LN scores. CONCLUSIONS: Our data indicate that different conformations of α-syn pathology are present in PD brain and correspond to different stages of maturity for Lewy pathology. Regional analysis of Syn7015 and Syn9029 immunostaining also provides support for the Braak hypothesis that α-syn pathology advances through the brain.
AIMS: The aim of this study was to test the hypothesis that different conformations of misfolded α-synuclein (α-syn) are present in Parkinson's disease (PD) brain. METHODS: Using two previously characterized conformations of α-syn fibrils, we generated new conformation-selective α-syn monoclonal antibodies (mAbs). We then interrogated multiple brain regions in a well-characterized autopsy cohort of PDpatients (n = 49) with these mAbs, Syn7015 and Syn9029. RESULTS:Syn7015 detects Lewy bodies (LBs) and Lewy neurites (LNs) formed by pathological α-syn in all brain regions tested, and is particularly sensitive to LNs and small Lewy dots, inclusions believed to form early in the disease. Further, we observed colocalization between Syn7015 and an early marker of α-syn pathology formation, phospho-Ser129-α-syn, and a lack of extensive colocalization with markers of more mature pathology. In comparison, Syn9029 detects Lewy pathology in all regions examined, but indicates significantly fewer LNs than Syn7015. In addition, colocalization of Syn9029 with later markers of α-syn pathology maturation (ubiquitin and P62) suggests that the pathology detected by Syn9029 is older. Semiquantitative scoring of both LN and LB pathology in nine brain regions further established this trend, with Syn7015 LN scores consistently higher than Syn9029 LN scores. CONCLUSIONS: Our data indicate that different conformations of α-syn pathology are present in PD brain and correspond to different stages of maturity for Lewy pathology. Regional analysis of Syn7015 and Syn9029 immunostaining also provides support for the Braak hypothesis that α-syn pathology advances through the brain.
Authors: W Peelaerts; L Bousset; A Van der Perren; A Moskalyuk; R Pulizzi; M Giugliano; C Van den Haute; R Melki; V Baekelandt Journal: Nature Date: 2015-06-10 Impact factor: 49.962
Authors: Kelvin C Luk; Cheng Song; Patrick O'Brien; Anna Stieber; Jonathan R Branch; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee Journal: Proc Natl Acad Sci U S A Date: 2009-11-05 Impact factor: 11.205
Authors: David J Irwin; Matthew D Byrne; Corey T McMillan; Felicia Cooper; Steven E Arnold; Edward B Lee; Vivianna M Van Deerlin; Sharon X Xie; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski Journal: J Histochem Cytochem Date: 2015-11-04 Impact factor: 2.479
Authors: Jon B Toledo; Vivianna M Van Deerlin; Edward B Lee; EunRan Suh; Young Baek; John L Robinson; Sharon X Xie; Jennifer McBride; Elisabeth M Wood; Theresa Schuck; David J Irwin; Rachel G Gross; Howard Hurtig; Leo McCluskey; Lauren Elman; Jason Karlawish; Gerard Schellenberg; Alice Chen-Plotkin; David Wolk; Murray Grossman; Steven E Arnold; Leslie M Shaw; Virginia M-Y Lee; John Q Trojanowski Journal: Alzheimers Dement Date: 2013-08-24 Impact factor: 21.566
Authors: Zsofia Lengyel-Zhand; John J Ferrie; Bieneke Janssen; Chia-Ju Hsieh; Thomas Graham; Kui-Ying Xu; Conor M Haney; Virginia M-Y Lee; John Q Trojanowski; E James Petersson; Robert H Mach Journal: Chem Commun (Camb) Date: 2020-03-24 Impact factor: 6.222
Authors: David Coughlin; Sharon X Xie; Mendy Liang; Andrew Williams; Claire Peterson; Daniel Weintraub; Corey T McMillan; David A Wolk; Rizwan S Akhtar; Howard I Hurtig; H Branch Coslett; Roy H Hamilton; Andrew D Siderowf; John E Duda; Katya Rascovsky; Edward B Lee; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski; David J Irwin Journal: Ann Neurol Date: 2019-01-07 Impact factor: 10.422
Authors: Garrett S Gibbons; Rachel A Banks; Bumjin Kim; Lakshmi Changolkar; Dawn M Riddle; Susan N Leight; David J Irwin; John Q Trojanowski; Virginia M Y Lee Journal: J Neuropathol Exp Neurol Date: 2018-03-01 Impact factor: 3.685
Authors: Michael X Henderson; Samantha Sedor; Ian McGeary; Eli J Cornblath; Chao Peng; Dawn M Riddle; Howard L Li; Bin Zhang; Hannah J Brown; Modupe F Olufemi; Danielle S Bassett; John Q Trojanowski; Virginia M Y Lee Journal: Neuron Date: 2019-12-30 Impact factor: 17.173
Authors: D G Coughlin; R Ittyerah; C Peterson; J S Phillips; S Miller; K Rascovsky; D Weintraub; A D Siderowf; J E Duda; H I Hurtig; D A Wolk; C T McMillan; P A Yushkevich; M Grossman; E B Lee; J Q Trojanowski; D J Irwin Journal: Neuropathol Appl Neurobiol Date: 2020-09-24 Impact factor: 8.090